Metronomic capecitabine in advanced hepatocellular carcinoma patients: A phase II study

Oncologist

Volumn 18, Issue 12, 2013, Pages 1256-1257

  Brandi, Giovanni ^a   De Rosa, Francesco ^a   Agostini, Valentina ^a   Di Girolamo, Stefania ^a   Andreone, Pietro ^a   Bolondi, Luigi ^a   Serra, Carla ^a   Sama, Claudia ^a   Golfieri, Rita ^a   Gramenzi, Annagiulia ^a   Cucchetti, Alessandro ^a   Pinna, Antonio Daniele ^a   Trevisani, Franco ^a   Biasco, Guido ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CAPECITABINE; SORAFENIB;

ARTICLE; COHORT ANALYSIS; DRUG EFFICACY; DRUG SAFETY; HUMAN; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; METRONOMIC DRUG ADMINISTRATION; OVERALL SURVIVAL; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL;

ADMINISTRATION, METRONOMIC; ADULT; AGED; AGED, 80 AND OVER; ANTIMETABOLITES, ANTINEOPLASTIC; CARCINOMA, HEPATOCELLULAR; DEOXYCYTIDINE; DISEASE-FREE SURVIVAL; DRUG RESISTANCE, NEOPLASM; FEMALE; FLUOROURACIL; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; NIACINAMIDE; PHENYLUREA COMPOUNDS; TREATMENT OUTCOME;

EID: 84890035796     PISSN: 10837159     EISSN: 1549490X     Source Type: Journal    
DOI: 10.1634/theoncologist.2013-0093     Document Type: Article

References (0)